| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4002825 | American Journal of Ophthalmology | 2013 | 9 Pages |
Abstract
Converting patients with chronic neovascular AMD to aflibercept results in stabilized vision and improved anatomic outcomes, while allowing injection intervals to be extended.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Yoshihiro Yonekawa, Christopher Andreoli, John B. Miller, John I. Loewenstein, Lucia Sobrin, Dean Eliott, Demetrios G. Vavvas, Joan W. Miller, Ivana K. Kim,